top of page

Novartis delivered solid third quarter

Net sales were USD 12.1 billion in the third quarter, as volume growth of 5 percentage points was more than offset by the negative impact of generic competition and pricing. Growth Products contributed USD 4.3 billion or 36% of net sales, up 20% (USD) over the prior-year quarter.




Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page